Latest News and Press Releases

DOVER, Del., March 19, 2025 (GLOBE NEWSWIRE) -- Cloudficient, a leader in seamless information governance and eDiscovery solutions, announces the release of Hyperlize™, an innovative new platform...

A large consumer packaged goods producer signed an agreement with Kneat to digitize validation in its life science division.

Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes.

Kneat signs a global and diverse medical devices manufacturer for digital validation.

Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked...

Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%

Kneat maintains 35% year-over-year revenue growth to surpass $10 million quarterly revenue mark, as annual recurring revenue growth accelerates to 57%.

Kneat has signed a Master Services Agreement with a global provider of critical care products with over 50,000 employees.

Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110.

Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning.